Clinical Trial

A Clinical Study to Investigate the Effect of Oral Neflamapimod on Motor Recovery After Acute Ischaemic Stroke

Study acronym: RESTORE
Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this interventional study is to determine whether neflamapimod can improve residual physical disability and/or cognitive dysfunction after Moderate to Severe Acute Ischaemic Stroke.
Protocol Amendment History 3 changes
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-07-09
notable Primary completion pushed: 2026-05-31 -> 2026-09-30 2026-07-09
minor Completion pushed: 2026-06-28 -> 2026-10-31 2026-07-09
Trial Details
NCT Number NCT06987643
Lead Sponsor EIP Pharma Inc
Collaborators: CervoMed, Inc.
Conditions Moderate to Severe Acute Ischaemic Stroke, Ischaemic Stroke
Enrollment 90 participants
Start Date 2025-06-20
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-08